Effects of Sublingual Immunotherapy on Grasspollen Allergy
A Placebo Controlled, Double-Blind, Randomised Study to Assess Efficacy of Sublingual Immunotherapy in Patients With Grass Pollen Allergy Through Assessment of Its Immunological Effects on the Mucosal Tissue of the Nose.
Sponsor: Radboud University Medical Center
A PHASE4 clinical study on Hayfever, this trial is completed. The trial is conducted by Radboud University Medical Center and has accumulated 5 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Mar 2022 [monthly]
Completed PHASE4
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE4
First recorded
Jan 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Radboud University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .